The clinical utility of the calcitonin gene–related peptide (CGRP) receptor antagonist ubrogepant may extend beyond the treatment of acute migraine to alleviating common prodromal symptoms of migraine ...

A dermatologist with erythropoietic protoporphyria herself presents results of the INSPIRE randomized controlled trial of dersimelagon.

A migraine drug called ubrogepant doesn't just reduce the severity of a migraine attack – it also dials down the non-headache symptoms in the prodrome: the hours leading up to the main event. That's ...

Please provide your email address to receive an email when new articles are posted on . Increased consumption of unprocessed foods boosted odds of nonmotor prodromal Parkinson’s symptoms. Greater odds ...

Results of a recent study found that administering the medication ubrogepant during the prodrome, or ‘onset,’ phase of migraine may greatly improve normal functioning abilities and reduce activity ...

Please provide your email address to receive an email when new articles are posted on . Participants with word-finding issues reported concentration trouble, and vice versa. No cognitive performance ...

Treatment with oral ubrogepant (Ubrelvy) during the migraine prodrome led to more patients being able to function normally, a prespecified secondary endpoint analysis of the phase III PRODROME trial ...

Absence of photophobia at 2 hours postdose occurred in 19.5 and 12.5% of ubrogepant- and placebo-treated events, respectively. HealthDay News — Ubrogepant during the prodromal phase of migraine may ...

Share on Pinterest Taken at onset, ubrogepant may stop migraine attacks in their tracks. Image credit: Guido Mieth/Getty Images. Migraine attacks are painful events that can cause many unpleasant ...